MAPT and Alzheimer disease: This hypothesis has served as the dominant theoretical framework guiding AD research for over three decades, highlighting Aβ aggregation as a trigger for downstream events such as tau pathology, synaptic dysfunction, neuroinflammation, and neuronal loss.